Sign Up
Select Language
English enFrançais fr中文 zhEspañol esУкраїнська ukFilipino fil한국어 koItaliano itPortuguês pt-brРусский ruDeutsch deNederlands nl
Logo
Ad
Layer2
Share this article

A DAO for Diseases: How Vibe Bio Plans to Retool Biotech Funding

Vibe Bio’s founder wasn’t passionate about creating a DAO – but decentralizing drug research could fix a thorny, tragic problem.

By David Z. Morris
Updated May 11, 2023, 6:10 p.m. Published Jul 15, 2022, 5:11 p.m.
Large pharmaceutical companies focus on fighting the most common (and therefore profitable) disorders. A new DAO wants to restructure incentives and boost research into rarer diseases. (Morsa/Getty Images)
Large pharmaceutical companies focus on fighting the most common (and therefore profitable) disorders. A new DAO wants to restructure incentives and boost research into rarer diseases. (Morsa/Getty Images)